{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:22:01Z","timestamp":1792207321938,"version":"4.4.0"},"reference-count":59,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Pulmonol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1002\/ppul.22826","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T05:56:21Z","timestamp":1371534981000},"page":"490-502","source":"Crossref","is-referenced-by-count":32,"title":["Use of palivizumab in infants and young children with severe respiratory disease: A delphi study"],"prefix":"10.1002","volume":"49","author":[{"given":"Mirella","family":"Gaboli","sequence":"first","affiliation":[{"name":"Pediatric Pulmonology and Pediatric Intensive Care Units, Department of Pediatrics; Hospital Universitario de Salamanca and University of Salamanca; Salamanca Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d2scar","family":"Asensio de la Cruz","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonology and Cystic Fibrosis Unit, Service of Pediatrics, Hospital de Sabadell, Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed, Sabadell; Universitat Aut\u00f2noma de Barcelona; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Barrio G\u00f3mez de Ag\u00fcero","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonology Unit, Service of Pediatrics; Hospital Universitario La Paz; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moreno-Gald\u00f3","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Departament de Pediatria, Obstetricia i Ginecologia i Medicina Preventiva; Universitat Aut\u00f2noma de Barcelona; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"P\u00e9rez P\u00e9rez","sequence":"additional","affiliation":[{"name":"Pediatric Pulmunology Unit, Service of Pediatrics; Hospital Universitario Virgen Macarena; Sevilla Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"S\u00e1nchez-Sol\u00eds de Querol","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonology Unit, Service of Pediatrics; Hospital Universitario Virgen de la Arrixaca; Murcia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"10.1002\/ppul.22826-BIB0001|ppul22826-cit-0001","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ppul.21377","article-title":"Respiratory syncytial virus prevention and therapy: past, present, and future","volume":"46","author":"Wright","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22826-BIB0002|ppul22826-cit-0002","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0378-3782(12)70012-9","article-title":"High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention","volume":"88","author":"Mazoni","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1002\/ppul.22826-BIB0003|ppul22826-cit-0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1874285801105010155","article-title":"Respiratory syncytial virus infection in children with neuromuscular impairment","volume":"5","author":"Simon","year":"2011","journal-title":"Open Microbiol J"},{"key":"10.1002\/ppul.22826-BIB0004|ppul22826-cit-0004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/cid\/cir928","article-title":"Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study","volume":"54","author":"Kristensen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1002\/ppul.22826-BIB0005|ppul22826-cit-0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1874285801105010144","article-title":"Risk factors for severe respiratory Syncytial Virus lower respiratory tract infection","volume":"5","author":"Sommer","year":"2011","journal-title":"Open Microbiol J"},{"key":"10.1002\/ppul.22826-BIB0006|ppul22826-cit-0006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.2008.139188","article-title":"Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus (RSV) infection","volume":"94","author":"Thorburn","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1002\/ppul.22826-BIB0007|ppul22826-cit-0007","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0b013e318235455b","article-title":"Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria","volume":"31","author":"Resch","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0008|ppul22826-cit-0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22826-BIB0009|ppul22826-cit-0009","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22826-BIB0010|ppul22826-cit-0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1157\/13124223","article-title":"Spanish multidisciplinary consensus on the prevention of respiratory syncytial virus infection in children","volume":"69","author":"Figueras Aloy","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1002\/ppul.22826-BIB0011|ppul22826-cit-0011","doi-asserted-by":"crossref","first-page":"432.e1","DOI":"10.1016\/j.anpedi.2010.03.001","article-title":"Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology","volume":"7","author":"Medrano L\u00f3pez","year":"2010","journal-title":"An Pediatr (Barc)"},{"key":"10.1002\/ppul.22826-BIB0012|ppul22826-cit-0012","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1111\/j.1651-2227.2012.02716.x","article-title":"Consensus in diagnostic definitions for bone or joint infections in children by a Delphi method with European French-speaking experts","volume":"101","author":"Mitha","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1002\/ppul.22826-BIB0013|ppul22826-cit-0013","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1546-0096-10-7","article-title":"Developing a standardized approach to the assessment of pain in children and youth presenting to pediatric rheumatology providers: a Delphi survey and consensus conference process followed by feasibility testing","volume":"10","author":"Stinson","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1002\/ppul.22826-BIB0014|ppul22826-cit-0014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phrs.2008.09.007","article-title":"Defining off-label and unlicensed use of medicines for children: results of a Delphi survey","volume":"58","author":"Neubert","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1002\/ppul.22826-BIB0015|ppul22826-cit-0015","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/j.1365-2702.2009.03025.x","article-title":"Research priorities for nursing care of infants, children and adolescents: a West Australian Delphi study","volume":"19","author":"Wilson","year":"2010","journal-title":"J Clin Nurs"},{"key":"10.1002\/ppul.22826-BIB0016|ppul22826-cit-0016","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1469-8749.2010.03899.x","article-title":"Identification of a core set of exercise tests for children and adolescents with cerebral palsy: a Delphi survey of researchers and clinicians","volume":"53","author":"Verschuren","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1002\/ppul.22826-BIB0017|ppul22826-cit-0017","volume-title":"The Delphi method, III: use of self ratings to improve group estimates","author":"Dalkey","year":"1969"},{"key":"10.1002\/ppul.22826-BIB0018|ppul22826-cit-0018","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-7-52","article-title":"An exploration of the use of simple statistics to measure consensus and stability in Delphi studies","volume":"7","author":"Holey","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1002\/ppul.22826-BIB0019|ppul22826-cit-0019","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"263","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1002\/ppul.22826-BIB0020|ppul22826-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7340","article-title":"Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system","volume":"7","author":"Royle","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1002\/ppul.22826-BIB0021|ppul22826-cit-0021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaci.2010.06.032","article-title":"The Asthma Predictive Index: a very useful tool for predicting asthma in young children","volume":"126","author":"Castro-Rodriguez","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/ppul.22826-BIB0022|ppul22826-cit-0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ppul.20741","article-title":"Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis","volume":"43","author":"Prasad","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22826-BIB0023|ppul22826-cit-0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.prrv.2009.06.002","article-title":"Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab","volume":"10","author":"Fitzgerald","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1002\/ppul.22826-BIB0024|ppul22826-cit-0024","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: Policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","author":"Committee on Infectious Diseases","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22826-BIB0025|ppul22826-cit-0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/INF.0b013e31805d01e3","article-title":"Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course","volume":"26","author":"Wilkesmann","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0026|ppul22826-cit-0026","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.prrv.2009.06.003","article-title":"Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes","volume":"10","author":"Resch","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1002\/ppul.22826-BIB0027|ppul22826-cit-0027","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00431-011-1654-8","article-title":"Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations","volume":"171","author":"Paes","year":"2012","journal-title":"Eur J Paediatr"},{"key":"10.1002\/ppul.22826-BIB0028|ppul22826-cit-0028","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/INF.0b013e3181d7ffa5","article-title":"Down syndrome and respiratory syncytial virus infection","volume":"29","author":"Megged","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0029|ppul22826-cit-0029","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/INF.0b013e318201813b","article-title":"Hospitalizations due to respiratory syncytial virus in children with congenital malformations","volume":"30","author":"Zachariah","year":"2011","journal-title":"Pediatr Infect Dis"},{"key":"10.1002\/ppul.22826-BIB0030|ppul22826-cit-0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10156-010-0121-1","article-title":"Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan","volume":"17","author":"Mori","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1002\/ppul.22826-BIB0031|ppul22826-cit-0031","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1542\/peds.2007-0788","article-title":"Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis-a prospective birth-cohort study","volume":"120","author":"Bloemers","year":"2007","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22826-BIB0032|ppul22826-cit-0032","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jpeds.2011.11.004","article-title":"Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study","volume":"160","author":"Zachariah","year":"2012","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22826-BIB0033|ppul22826-cit-0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/adc.73.2.117","article-title":"Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis","volume":"73","author":"Smyth","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1002\/ppul.22826-BIB0034|ppul22826-cit-0034","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"156","author":"Armstrong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/ppul.22826-BIB0035|ppul22826-cit-0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1203\/pdr.0b013e3180332d1c","article-title":"RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells","volume":"61","author":"Van Ewijk","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1002\/ppul.22826-BIB0036|ppul22826-cit-0036","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22711","article-title":"Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis","author":"Winterstein","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22826-BIB0037|ppul22826-cit-0037","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007743.pub3","article-title":"Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis (review)","author":"Robinson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/ppul.22826-BIB0038|ppul22826-cit-0038","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001753.pub2","article-title":"Vaccines for preventing influenza in people with cystic fibrosis","author":"Dharmaraj","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/ppul.22826-BIB0039|ppul22826-cit-0039","doi-asserted-by":"publisher","first-page":"e1016","DOI":"10.1542\/peds.2008-0160","article-title":"Prevention of influenza: recommendations for influenza immunization of children, 2007-2008","volume":"121","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/ppul.22826-BIB0040|ppul22826-cit-0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcf.2004.10.003","article-title":"Immunisation in the current management of cystic fibrosis patients","volume":"4","author":"Malfroot","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1002\/ppul.22826-BIB0041|ppul22826-cit-0041","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ppul.20751","article-title":"Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis","volume":"43","author":"Giebels","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1002\/ppul.22826-BIB0042|ppul22826-cit-0042","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1442-200X.2008.02580.x","article-title":"Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia","volume":"50","author":"Masumoto","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1002\/ppul.22826-BIB0043|ppul22826-cit-0043","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/INF.0b013e31821146f7","article-title":"CARESS: the Canadian registry of palivizumab","volume":"30","author":"Mitchell","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0044|ppul22826-cit-0044","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-6143.2011.03490.x","article-title":"Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies","volume":"11","author":"Vu","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1002\/ppul.22826-BIB0045|ppul22826-cit-0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/653529","article-title":"Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients","volume":"51","author":"Soccal","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1002\/ppul.22826-BIB0046|ppul22826-cit-0046","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1600-6143.2005.00971.x","article-title":"Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant","volume":"5","author":"Kumar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1002\/ppul.22826-BIB0047|ppul22826-cit-0047","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1399-3046.2008.01017.x","article-title":"Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers","volume":"13","author":"Michaels","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1002\/ppul.22826-BIB0048|ppul22826-cit-0048","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-3046.2012.01744.x","article-title":"RSV prevention and treatment in pediatric lung transplant patients: a survey of current practices among the International Pediatric Lung Transplant Collaborative","volume":"16","author":"Danziger-Isakov","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1002\/ppul.22826-BIB0049|ppul22826-cit-0049","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.inf.0000108220.94201.1a","article-title":"Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease","volume":"23","author":"Cabalka","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0050|ppul22826-cit-0050","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.arcped.2004.06.007","article-title":"Use of palivizumab for the prevention of respiratory syncytial virus infections in children with congenital heart disease. Recommendations from the French Paediatric Cardiac Society [Article in French]","volume":"11","author":"Chantepie","year":"2004","journal-title":"Arch Pediatr"},{"key":"10.1002\/ppul.22826-BIB0051|ppul22826-cit-0051","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"151","author":"Simoes","year":"2007","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22826-BIB0052|ppul22826-cit-0052","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Sim\u00f5es","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/ppul.22826-BIB0053|ppul22826-cit-0053","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/314523","article-title":"Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein","volume":"178","author":"Malley","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1002\/ppul.22826-BIB0054|ppul22826-cit-0054","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/322043","article-title":"Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants","volume":"184","author":"Boeckh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1002\/ppul.22826-BIB0055|ppul22826-cit-0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00006454-199802000-00006","article-title":"Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia","volume":"17","author":"Subramanian","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0056|ppul22826-cit-0056","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1517\/14656566.9.14.2451","article-title":"Respiratory syncytial virus bronchiolitis: prevention and treatment","volume":"9","author":"Faber","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1002\/ppul.22826-BIB0057|ppul22826-cit-0057","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.inf.0000133165.85909.08","article-title":"Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection","volume":"23","author":"S\u00e1ez-Llorens","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0058|ppul22826-cit-0058","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e3181343b7e","article-title":"Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients","volume":"26","author":"Ch\u00e1vez-Bueno","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22826-BIB0059|ppul22826-cit-0059","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2009.07763.x","article-title":"Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience","volume":"146","author":"Tsitsikas","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22826","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22826","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ppul.22826\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T22:37:10Z","timestamp":1625351830000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.22826"}},"subtitle":["Palivizumab in Pediatric Severe Respiratory Disease"],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1002\/ppul.22826","archive":["Portico"],"relation":{},"ISSN":["8755-6863"],"issn-type":[{"value":"8755-6863","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}